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Forty-five years ago a naturally attenuated tick-borne flavivirus, Langat (LGT) strain TP21, was recovered from ticks in
Malaysia. Subsequently, it was tested as a live attenuated vaccine for virulent tick-borne encephalitis viruses. In a large
clinical trial its attenuation was confirmed but there was evidence of a low level of residual virulence. Thirty-five years ago
further attenuation of LGT TP21 was achieved by multiple passages in eggs to yield mutant E5. To study the genetic
determinants of the further attenuation exhibited by E5 and to allow us to manipulate the genome of this virus for the purpose
of developing a satisfactory live attenuated tick-borne flavivirus vaccine, we recovered infectious E5 virus from a full-length
cDNA clone. The recombinant E5 virus (clone 651) recovered from a full-length infectious cDNA clone was more attenuated
in immunodeficient mice than that of its biologically derived E5 parent. Increase in attenuation was associated with three
amino acid substitutions, two located in the structural protein E and one in nonstructural protein NS4B. Subsequently an even
greater degree of attenuation was achieved by creating a viable 320 nucleotide deletion in the 39-noncoding region of
infectious full-length E5 cDNA. This deletion mutant was not cytopathic in simian Vero cells and it replicated to lower titer
than its E5-651 parent. In addition, the E5 39 deletion mutant was less neuroinvasive in SCID mice than its E5-651 parent.
Significantly, the deletion mutant proved to be 119,750 times less neuroinvasive in SCID mice than its progenitor, LGT strain
TP21. Despite its high level of attenuation, the E5 39 deletion mutant remained highly immunogenic and intraperitoneal (ip)
inoculation of 10 PFU induced complete protection in Swiss mice against subsequent challenge with 2000 ip LD50 of the
wild-type LGT TP21.INTRODUCTION
Langat virus (LGT) belongs to the tick-borne enceph-
alitis virus (TBEV) complex, within the genus Flavivirus of
the family Flaviviridae. There are more than 60 antigeni-
cally related, positive-strand RNA flaviviruses, many of
which cause considerable morbidity and mortality in hu-
mans (Calisher et al., 1989; Monath and Heinz, 1996).
Langat virus initially recovered from ticks in Malaysia did
not appear to be associated with human disease under
natural conditions (Smith, 1956). Also, LGT has been
shown to be effective in inducing cross-reactive neutral-
izing antibodies and in preventing disease caused by
tick-borne encephalitis complex flaviviruses in experi-
mental animals (Nathanson et al., 1968; Price et al., 1970;
Price and Thind, 1973; Pletnev et al., 2000). For this
reason, LGT virus was considered as a live attenuated
vaccine for prevention of tick-borne encephalitis which is
a widespread disease in many European and Asian
countries. Several LGT derivatives were isolated and
shown to be partially attenuated for mice and monkeys
1 To whom reprint requests should be addressed at National Insti-
Nutes of Health, NIAID, 7 Center Dr. MSC 0740, Building 7, Room 236,
ethesda, MD 20892. E-mail: apletnev@niaid.nih.gov.
0042-6822/01
288(Thind and Price, 1966a; Il’enko et al., 1968; Mayer et al.,
1976; Smoridincev and Dubov, 1986). One such strain,
designated E5, was selected by 42 passages of the wild
LGT TP21 strain in embryonated chicken eggs (Thind
and Price, 1966a,b). LGT E5 virus differed from the wild
LGT TP21 strain by its lower peripheral neurovirulence
(“neuroinvasiveness”) for mice, low neurovirulence in
Ateles geoffroyi monkeys inoculated intracerebrally, as
well as Macaca mulatta monkeys inoculated intraspi-
nally. Based on assessment of histological lesions in
central nervous system (CNS) of rhesus monkeys, the
attenuated LGT E5 strain exhibited reduced neuroviru-
lence that was less than that of 17D yellow fever virus
vaccine but greater than that of the attenuated poliovirus
type 3 oral vaccine strain (Nathanson et al., 1968).
Recently, the complete sequence of wild-type LGT
virus (TP21 strain) genome and its more attenuated E5
derivative was determined (Campbell and Pletnev, 2000).
There were 12 nucleotide differences in the consensus
sequence of the two LGT strains (parental TP21 and its
derivative E5), of which seven produced an amino
acid substitution in the envelope structural protein E
(Phe119 3 Val and Asn389 3 Asp), nonstructural proteinS3 (Asn22 3 Ser, Phe248 3 Tyr and Phe317 3 Leu), and
NS5 (Ser422 3 Thr and Arg542 3 Lys). These mutations
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289DECREASED NEUROINVASIVENESS IN IMMUNODEFICIENT MICEwere associated with a difference in neuroinvasiveness
of these LGT strains in Swiss mice observed earlier
(Pletnev and Men, 1998). LGT TP21 was at least 2000
times more neuroinvasive than its E5 derivative when
tested in immunocompetent mice. Only 10–20% of adult
Swiss mice inoculated intraperitoneally with 107 PFU of
5 developed signs of encephalitis. Both strains were
ighly immunogenic in animals. A low dose of either
P21 or E5 (i.e., 10 or 102 PFU) was immunogenic as
measured by induction of serum neutralizing antibodies
(Pletnev and Men, 1998). Significantly, infection with LGT
TP21 or E5 provided protection against challenge with
tick-borne encephalitis virus (European or Far Eastern
strain; Pletnev et al., 2000). Nevertheless, LGT E5 exhib-
its very little evidence of neuroinvasiveness in normal
mice even when inoculated in high dose. Ideally, live
attenuated tick-borne flavivirus vaccines should be free
of this very low level of residual virulence. Thus, before
considering the attenuated E5 strain of LGT as a possi-
ble candidate for use in prophylaxis of human TBE dis-
ease, we attempted to remove the last vestiges of pe-
ripheral neurovirulence of LGT E5 for experimental animals
by constructing a full-length infectious clone of LGT E5. The
availability of such an infectious clone would allow us to
introduce site-specific mutations into the infectious cDNA
clone and evaluate their effect on virulence.
Previously, we found that the immunodeficient mouse
to be an extraordinarily sensitive assay system for de-
tecting low levels of residual virulence of LGT E5. The
ability of SCID mice to detect neuroinvasiveness of E5
was approximately 108 greater than was the case for
ormal mice. In the present study an infectious cDNA
lone of LGT E5 was constructed and used to identify
utations that diminished neuroinvasiveness of the
lready partially attenuated LGT E5 mutant without de-
onstrable diminution of immunogenicity or protective
fficacy.
RESULTS
onstruction of full-length E5 cDNA clone and
ecovery of virus from cells transfected
ith full-length RNA transcripts
Recently we succeeded in constructing stable LGT
P21 full-length cDNA clones from which infectious RNA
ould be transcribed in vitro (Campbell and Pletnev,
2000). One of these full-length cDNA clones, plasmid
pTP21–636, was used to create full-length cDNA of E5
genome by replacing almost the entire TP21 genome
with the corresponding sequence of E5 strain. The com-
plete nucleotide sequence of the wild-type LGT virus
(TP21 strain) genome and its more attenuated derivative,
strain E5, was determined previously from cDNA frag-
ments produced by RT-PCR (GenBank accession nos.
AF253419 and AF253420). The TP21 and E5 genomes
were both 10,943 nucleotides (nt) in length and containeda 130 nt 59 noncoding region (NCR) and a 568 nt 39 NCR
that were completely conserved. Twelve differences in
genome sequence of TP21 and E5 strain were located
between nucleotide positions 1325 and 9288. This region
together with flanking conserved sequences (nts 133 to
1324 and nts 9289 to 9737) in the infectious cDNA of
cloned full-length TP21 genome was targeted for substi-
tution with the corresponding sequence of E5 (Fig. 1A).
An almost full-length cDNA fragment (;10.5 kb) of the E5
genome was prepared by high-fidelity long PCR using an
RT product derived from viral RNA extracted from a
low-titered E5 virus stock (1.2 3 104 PFU/ml). Low-titered
irus harvested early in the growth cycle was used to
repare cDNA as template for PCR to minimize the pres-
nce of mutants with large 39 deletions or rearranged
enomes that accumulate late in infection as observed
reviously (Campbell and Pletnev, 2000). Conservation of
he 59 132 nts and the 39 1205 nts of TP21 and E5 allowed
s to clone the PCR product of the E5 genome, spanning
ts 133 to 9737, into the pTP21–636 vector replacing the
orresponding TP21 sequence. Six stable full-length E5
DNA clones were identified by restriction enzyme di-
estion pattern. The partial sequence of these plasmids
pE5) was analyzed and found to contain the E5-specific
equences that differentiate E5 from its TP21 parent
Campbell and Pletnev, 2000).
Prior to producing run-off transcripts, the plasmid DNA
emplate was linearized using EcoRV, whose cleavage
ite is present three nucleotides downstream of the 39
nd of LGT E5 sequence. Full-length RNA generated by
P6 polymerase from six different plasmids was tested
or infectivity by transfection of CEF cells or simian Vero
ells. Only one E5 cDNA clone (pE5-651) was infectious
or both cell lines while the other clones were not viable.
vidence of virus infection was detected by IFA with
GT-specific hyperimmune mouse ascitic fluid (HMAF).
ll of the transfected Vero cells and 20–30% of CEF-
ransfected cells were positive on day 5. Stock prepara-
ions of the rescued E5 clone were produced by passag-
ng the virus once or 12 times in the cell line used for
escue and harvesting the supernatant medium of in-
ected cultures. After one or 12 passages in Vero or CEF
ells, virus was analyzed for deviation of sequence from
ts biologically derived E5 parent.
enetic variability of E5-651 virus during construction,
ecovery, and passage in cell culture
The complete sequence of the E5-651 virus genome
escued from cDNA in Vero or CEF cells was determined
by analysis of overlapping RT-PCR cDNA fragments, de-
rived directly from virus RNA, and compared with the
consensus sequence of its parental E5 virus (Campbell
and Pletnev, 2000) as well as the nucleotide sequence of
the viral insert in the pE5-651 plasmid from which infec-
tious RNA transcripts were derived (Table 1). The res-
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290 ALEXANDER G. PLETNEVcued E5-651 clone contained the E5 consensus se-
quence in the 12 positions at which the wild-type TP21
parent differed from its E5 derivative. Analysis of the
plasmid DNA revealed eight differences in nucleotide
sequence from the consensus sequence of E5, of which
three produced an amino acid substitution in the enve-
FIG. 1. Construction of full-length cDNA of LGT E5 genome. (A) The
pTP21-636 which was cloned and sequenced as described earlier (C
derived by long PCR. (B) Construction and location of the deletions in t
KpnI, and EcoRV in the cDNA shown in (A) or (B) by dashed lines. So
horizontal arrows indicate position of SP6 promoter or position of prim
numbers at the ends of LGT cDNA fragments represent the first and the
from the results of RT-PCR sequence of E5 genome (GenBank accession
extends from nt 10379 to the position indicated on top of the striped b
cDNA genomes. The LGT E5 nucleotide sequence is in bold letters. T
codon indicated by the underlined sequence. The size of deletion, itslope structural protein E (Glu149 3 Gly and Glu291 3 Gly)
and nonstructural protein NS4B (Ala183 3 Val).
t
tThe sequence of the first passage Vero cell grown
lone E5-651 did not differ from the plasmid cDNA se-
uence, whereas after 12 passages in Vero cells fluctu-
tion between (i) Ser17 and Asn and (ii) Gln383 and Lys
as identified in NS2B and NS3, respectively. E5-651
escued and passaged once in CEF cells differed from
bly of full-length cDNA of E5 in a plasmid was performed using the
ll and Pletnev, 2000) and the SfiI(133)–AgeI(9737) fragment that was
CR of E5 genome. Position of the cleavage site of NotI, SfiI, AgeI, AflII,
s indicate PCR cDNA fragments derived from the E5 genome. Short
rtical solid arrows indicate subsequent steps in cloning strategy. The
ucleotide positions of the genome, respectively. NT numbering derived
253420). The position of the introduced deletion into the 39-NCR, which
shown. (C) Sequence of the 39-NCR junctions of the deletion mutant
I cleavage site, which was used to generate deletions, and TAA-stop
n, and corresponding plasmid construct is shown.assem
ampbe
he 39-N
lid line
er; ve
last n
no. AF
oxes, ishe plasmid DNA sequence at 2 nt positions in E; one of
he changes resulted in fluctuation between C and U at
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291DECREASED NEUROINVASIVENESS IN IMMUNODEFICIENT MICEnt position 1151 of E and fluctuation between Gly149 and
Arg at nt position 1415 of E. When CEF cell culture-
derived virus was passaged an additional 11 times in
CEF cells, only U (nt 1151) or A (nt 1415) was selected
from the fluctuation mixture. In addition, four other sub-
stitutions were identified, two of which a produced a
coding change (Table 1). In contrast, only two positions
4254 (G/A) and 5744 (C/A) in genome sequence varied
after 12 passages of E5-651 virus in Vero cells. Because
the frequency of E5-651 genomic changes in CEF cells
was greater than that observed in Vero cells, the Vero
cell culture-derived E5-651 virus was selected on the
basis of its apparent greater stability to be used for
analysis of mouse neuroinvasiveness. Before evaluating
virus virulence in mice, E5-651 virus was subjected to
plaque-to-plaque purification to minimize the accumula-
tion of spontaneous mutations, which might occur during
virus amplification in Vero cells.
Plaquing efficiency and purification of E5 clone
in cell culture
Plaque phenotype of the rescued E5-651 virus recov-
ered from Vero cells and passaged once in these cells
was examined using simian LLCMK2 and Vero cells. The
rescued Vero cell culture-derived E5-651 virus produced
T
Changes from Consensus Sequence of E5 That Occurred d
in Simian Vero or Chicken Emb
Genome
region
NT
position
Sequence of
parental E5 Plasmid pDNA
59NCR 53 U
E 1151 C
1358 C
1415 G
1416 A G (Glu149 3 Gly)
1485 C
1842 A G (Glu291 3 Gly)
NS1 3046 U C
3154 U C
NS2B 4254 G
NS3 4528 U C
4675 C
5744 C
NS4B 6955 C U
7294 G A
7455 C U (Ala183 3 Val)
Note. Coding changes are positioned left of center whereas non-co
arrow denotes a coding or non-coding change that is conserved subssmall clear transparent plaques 1.5 mm in diameter on
LLCMK2 cells 7 days postinfection (Table 2). In contrast,
athis virus produced smaller (,0.1 mm) faint plaques in
Vero cells. In comparison, parental E5 virus grown in
Vero cells produced large plaques (5.0–5.2 mm) on both
Vero and LLCMK2 cells. Clone E5-651 rescued and
rown in CEF cells exhibited the same plaque size and
orphology in the two simian cell cultures as Vero cell-
erived virus (data not shown).
Individual 1.5-mm plaques of E5-651 were harvested
rom LLCMK2 cells infected with Vero cell culture-derived
virus and then subjected to three additional plaque-to-
plaque passages in LLCMK2 cells. Seed stock of the
plaque-purified isolate of E5-651 virus was prepared fol-
lowing further amplification in Vero cells. Difference of
plaque phenotype of the E5-651 virus in Vero and
LLCMK2 cells did not change following plaque-to-plaque
election in LLCMK2 cells and amplification in Vero cell
culture. In addition, the plaque-purified isolate did not
differ in sequence from its rescued E5-651 virus.
Evaluation of cDNA-derived E5 virus in mice
Previously, wild-type strain TP21 was shown to be
virulent for 3-week-old Swiss mice with an intraperito-
neal LD50 of 5 3 103 PFU (Pletnev and Men, 1998). In
ontrast, the attenuated E5 strain derivative of TP21 ex-
ibited neuroinvasiveness in adult mice only when the
7 8
loning, Rescue of E5 from Full-Length cDNA, and Passage
Fibroblast (CEF) Cell Culture
Deviation from E5 consensus sequence
Rescued E5-651 isolated or passaged in
Vero CEF
age 1 Passage 12 Passage 1 Passage 12
C
C/U U
U (His130 3 Tyr)
G/A (Glu149/Arg) A (Glu149 3 Arg)
C/U(Thr172/Ile)
G/A (Ser17/Asn)
A
C/A (Gln383/Lys)
anges are positioned in the center of their respective columns. Long
ly.







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Passmount of virus inoculated was increased to 10 -10 PFU.
In the earlier study SCID mice were shown to be at least
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292 ALEXANDER G. PLETNEV106-108 times more permissive than normal mice for
etection of peripheral neurovirulence of Langat virus
trains. For this reason, three-week-old SCID mice in
roups of 5 were inoculated ip with decimal dilutions of
5-651 or with 1 PFU of parental E5 strain whose LD50
ad previously been determined to be 0.06 PFU (Pletnev
nd Men, 1998). 105 PFU of chimera TP21/DEN4(vac)
was also evaluated ip in SCID mice as a negative control
because a previous study indicated that it lacked any
evidence for neuroinvasiveness (ip LD50 of .107 PFU;
Pletnev and Men, 1998; Pletnev et al., 2000). Parental E5
irus caused 100% mortality within 9 to 13 days after ip
noculation of 1 PFU, whereas 105 PFU of the chimeric
virus failed to cause fatal disease over a period of 7
weeks. However, 2 of 5 mice died 28 or 33 days following
ip inoculation of 100 PFU of E5-651. In a subsequent
experiment, groups of five SCID mice were inoculated ip
with decimal dilutions of clone E5-651, and its LD50 was
determined to be 20.4 PFU (21.0 PFU in repeat experi-
ment). Thus, clone E5-651 was 5.1 3 103 times less
euroinvasive than strain TP21 which had an estimated
D50 for SCID mice of 0.004 PFU and 3.4 3 102 times
less virulent than its immediate parental E5 virus which
had an estimated LD50 of 0.06 PFU for SCID mice (Plet-
nev and Men, 1998).
Construction of 39-NCR deletion mutants and virus
recovery
In an attempt to increase the level of attenuation of
clone E5-651 for SCID mice, several strategic mutations
were introduced in its cDNA genome. With regard to the
development of an attenuated live flavivirus vaccine, any
T
Lineage and Reduction of Neuroinvasiveness of Langat
from Full-Length cDNA and Deletion
LGT strain Derivation
Plaque sizea (
in simian ce
LLCMK2 V
TP21 Isolated from ticks 5.0
E5 42 passages in eggs 5.0
E5-651 Recovered from full-length cDNA
in Vero cells
1.5 ,
E5-39-320 320 nt deletion in 39 NCR of genome
recovered in Vero cells
;0.2 No p
a Plaque size on day 7 post-infection.
b Data were taken from growth curve analysis (shown in Fig. 2) whe
by a day 5 immunostaining focus-forming assay (see Materials and M
c Data from Pletnev and Men, 1998.attenuating mutations introduced into the candidate vac-
cine virus should be genetically stable and not able toeffect a significant reduction in immunogenicity and pro-
tective efficacy. Recent studies involving several flavivi-
ruses suggest that 39-NCR deletions meet these require-
ments (Men et al., 1996; Mandl et al., 1998). The 39-NCR
of the RNA genome of tick-borne flaviviruses varies from
393 to 800 nt in length, of which only the last approxi-
mately 340 nts (core element) are more conserved than
the region between the stop codon of the open reading
frame and the core element (Dobrikova and Pletnev,
1995; Mandl et al., 1998). A recent study of TBEV provided
evidence that a 39-NCR deletion could reduce virulence
without loss of viability if the deletion extended from the
stop codon of the viral polyprotein to the beginning of the
core element (Mandl et al., 1998).
We introduced deletions that start at the fifth nucleo-
tide following the TAA-stop codon of the long open read-
ing frame and extend to targeted nucleotides indicated in
Figs. 1B and 1C. All mutant constructs contained an
additional three or five nucleotides that created an AflII
restriction enzyme cleavage site at the site of deletion
(Fig. 1C). The final mutant plasmids pE5-39-320, pE5-39-
374, pE5-39-449, and pE5-39-471 contained a deletion
320, 374, 449, or 471 nt in length, respectively.
Vero cells were transfected with full-length genomic
RNA transcripts prepared from full-length cDNA of the
39-NCR deletion mutants described above. Only E5-39-
320 mutant RNAs yielded viable virus. These results
were consistent with those observed for TBEV 39-NCR
deletion mutants (Mandl et al., 1998). Extension of dele-
tion into the core element of the 39 end TBEV or LGT
genome abolishes virus viability. The longest deletion of
TBEV compatible with viability retains the last 222 nts of
GT) during Passage in Eggs and Subsequent Recovery
0 nt from Its 39 Non-Coding Region
Titer (FFU/ml)b
attained in cell
culture at 5 days
Neuroinvasiveness of Vero
cell-grown virus for
SCID mice inoculated ip
LLCMK2 Vero LD50 (PFU)
Fold reduction compared to
Immediate parent TP21
2.8 3 108 1.9 3 109 0.004c
2.4 3 107 2.3 3 108 0.06c 15 15
4.4 3 106 1.7 3 108 20.4 340 5,100
5.0 3 105 1.5 3104 479 23.5 119,750
I was 0.01 and virus titer in medium of infected cells was determined
).ABLE 2
Virus (L
of 32
mm)
lls
ero
4.0
5.2
0.1
laques
re MOthe 39 end. The 39-NCR of rescued E5-39-320 virus con-
tains the last 244 nts of its genome.
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293DECREASED NEUROINVASIVENESS IN IMMUNODEFICIENT MICECharacterization of the rescued 39-NCR
deletion mutant
The rescued E5-39-320 differed from the E5-651 clone
with respect to plaque morphology in simian cells. The
39-NCR deletion mutant failed to produce visible plaques
on Vero cells, the cell substrate in which this virus was
recovered (Table 2). The mutant produced plaques on
LLCMK2 cells, but they were very small, less than 0.2
m. Such individual plaques were harvested and then
ubjected to three plaque-to-plaque passages in the
LCMK2 cell line. Finally, seed stock suspension of E5-
9-320 virus was prepared by additional amplification in
ero cells. The complete genome sequence of the E5-
9-320 mutant was determined and compared with se-
uence of E5-651 clone. The only difference detected
as the 39-NCR deletion of the E5–39-320 mutant.
The replication efficacy of parental E5, recombinant
5-651, and its 39-NCR deletion mutant was assayed
sing LLCMK2 or Vero cells inoculated with a multiplicity
of infection (m.o.i.) of 0.01 (Fig. 2). In Vero cells growth of
5-39-320 was 104 less than that of its E5-651 parent or
5 parent itself. The deletion mutant also grew less well
n LLCMK2 cells but it was restricted only 9- to 50-fold
Fig. 2 and Table 2).
euroinvasiveness of 39-NCR deletion mutant
n SCID mice
Neuroinvasiveness of E5-651 and its E5-39-320 dele-
ion mutant was evaluated in SCID mice in groups of five
noculated ip with decimal dilutions of virus. The recom-
inant 39-NCR deletion mutant was less virulent for SCID
ice than its immediate E5-651 parent. The estimated ip
D50 for E5-39-320 was 479 PFU compared to 20.4 PFU
FIG. 2. Analysis of growth of parental E5 and its recombinant deriv
ndicated virus at m.o.i. of 0.01 and following virus adsorption for 1 h, in
as harvested at indicated times and its titer was determined by a fo
ethods.or E5-651. Overall, the cloned E5-651 and E5-39-320
iruses were 5100 and 119,750 times less neuroinvasive,
m
despectively, than their wild-type progenitor, LGT TP21
irus.
haracterization of virus recovered from the brain
f moribund SCID mice inoculated ip with E5
r its recombinant derivatives
Death of mice inoculated ip with E5-651 or E5-39-320
as delayed by a factor of 2 compared to that of mice
noculated with their biologically derived E5 parent (Plet-
ev and Men, 1998; Campbell and Pletnev, 2000). This
elay is consistent with the increase in attenuation of the
ecombinant viruses as measured by ip LD50 in SCID
ice. In an attempt to explain the observed significant
elay in onset of encephalitis, we sequenced the full
enome of the brain isolates and compared the se-
uence to that of the virus that was inoculated ip (Table
). The brain isolates differed from the virus used to
nitiate infection by at most three coding changes in E,
S1, NS2B, NS3, NS4B, or NS5. Three of the brain iso-
ates sustained three coding changes, while the remain-
ng two viruses differed from inoculated virus at only one
mino acid position. Two brain isolates from SCID mice
noculated ip with 4.9 LD50 or 49 LD50 of recombinant
5-651 shared two coding changes, one at nt 1571 [G3 A
Ala2013 Thr) or G3 G/A (Ala2013 Ala/Thr)] and the other
t nt 5794 [G 3 U (Glu399 3 Asp) or G 3 G/U (Glu399 3
Glu/Asp)]. All of the other seven coding changes were
unique, i.e., not shared with other isolates. Clearly, addi-
tional study will be required to link any of these mutations
to increased neuroinvasiveness and/or neurovirulence.
In an initial attempt to clarify this situation, a mouse
brain isolate of E5-651 that contained the unique amino
acid substitution (His130 3 Tyr) in E (Table 3) was pas-
aged once in Vero cells and then tested in five SCID
ruses in simian LLCMK2 and Vero cells. Cells were infected with the
was removed and fresh medium was added. Virus in culture medium
ing assay on the respective cells as described under Materials andative vi
oculumice by ip inoculation of 1 or 10 PFU. All inoculated mice
ied during the 14-day observation period. In addition,
ding ch
i
294 ALEXANDER G. PLETNEVthe mouse brain isolate of E5-39-320 virus that contained
the unique amino acid substitution (Gly149 3 Glu) in E
(Table 3) and that was also passaged once in Vero cells
was lethal for 100 or 80% of SCID mice inoculated ip with
1000 or 100 PFU, respectively. These findings suggest
that the observed spontaneous mutations in neuroinva-
sive isolates of the recombinant E5-651 and E5-39-320
are responsible for the increased neuroinvasiveness of
these mutants in immunodeficient mice.
Immunogenicity and protective efficacy of parental E5
and its recombinant E5-651 or E5-39-320 virus
Three-week-old outbred Swiss female mice (7–9 g)
were inoculated ip with decimal dilutions of parental E5
or its cDNA-derived E5-651 or E5-39-320 virus (Table 4).
Twenty-two days after inoculation, immunized as well as
nonimmunized (control) mice were bled to measure the
titer of serum neutralizing antibodies against LGT TP21.
All immunized mice seroconverted. Mice immunized ip
with 10 PFU of parental virus or either of its recombinants
developed a moderate to high titer of neutralizing anti-
bodies against LGT TP21. However, immunization with
10- or 100-fold more virus increased the titer of TP21
neutralizing antibodies attained. There was no signifi-
cant difference in the highest serum antibody titer in-
duced by parental E5 or either of its recombinant deriv-
atives in Swiss mice.
On day 23 postimmunization, mice were challenged ip
with 2000 ip LD50 of the wild-type LGT TP21 strain. Mice
T
Non-Coding or Coding Changes in Virus Recovered fro
of E5 or Recombinant cDNA-Deriv
Genome
region
Nucleotide
position
Deviation of sequence of brain is
Uncloned E5,
inoculum 16.7 LD50
a
Recom
Inoculum 4.9 LD50
b
E 1071
1358
1416
1571 G 3 A (Ala201 3 Thr)
2175 U 3 U/C (Val402 3 Ala)
NS1 3381 U 3 U/C (Val308 3 Ala)
NS2A 3523 G 3 A
3952
NS2B 4254 G 3 A (Ser17 3 Asn)
NS3 5518 C 3 C/U
5794 G 3 U (Glu399 3 Asp)
5896 A 3 G
NS4B 7432 C 3 C/U
7455 C 3 C/U (Ala183 3 Val)
NS5 10333 C 3 U
Note. Coding changes are positioned left of center whereas non-coimmunized ip with 10 PFU of E5, or E5-651, or E5-39-320
were completely protected against lethal TP21 chal-
vlenge, whereas none of the control mice survived chal-
lenge. It is noteworthy that the more attenuated mutant
(E5-39-320) which exhibited restricted growth in cell cul-
ture and a significant reduction in neuroinvasiveness for
SCID mice was able to induce complete protective im-
munity in immunocompetent mice at such a low immu-
nization dose. These data provide a basis for proposing
that the E5 39 deletion mutant be considered a candidate
vaccine strain that might serve as a stand-alone vaccine.
n of Moribund Mice 14 or 28 Days after ip Inoculation
Clone E5-651 or Clone E5-39-320)
om indicated virus inoculated 14a or 28b days previously
DNA-derived clone E5-651 Recombinant cDNA-derived
clone E5-39-320,
inoculum 2.1 LD50
bculum 49 LD50
a Inoculum 490 LD50
a
C/U (Thr34 3 Met)
C 3 U (His130 3 Tyr)
G 3 A (Gly149 3 Glu)
G/A (Ala201 3 Thr)
G 3 G/A
A 3 U
G/U (Glu399 3 Asp)
A 3 A/G
anges are positioned in the center of their respective columns.
TABLE 4
Antibody Response and Protective Efficacy of LGT
Virus Strains in Swiss Mice
Immunizing virus
Geometric mean of
serum neutralizing
antibody titer
(reciprocal)a
Mortality after ip
challenge with
2000 ip LD50
of TP21bStrain Dose (PFU)
E5 103 448 0/5
102 237 0/5
10 110 0/10
E5-651 103 372 0/10
102 152 0/10
10 130 0/10
E5-39-320 104 363 0/9
103 282 0/10
102 271 0/9
10 225 0/10
Control NA ,20 9/9
a Neutralizing antibodies in mouse serum collected 22 days after
mmunization were measured by a 50% focus reduction test using TP21ABLE 3
m Brai
ed E5 (
olate fr
binant c
Ino
C 3
G 3
G 3irus.
b Number of mice that died/number of mice tested.
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295DECREASED NEUROINVASIVENESS IN IMMUNODEFICIENT MICEAlternatively, this mutant could provide a foundation for
further alteration to yield a live virus vaccine for use in
preventing disease caused by antigenically related tick-
borne flaviviruses.
DISCUSSION
Rescue of LGT strain E5 from full-length cDNA was
achieved by replacing the coding region and short flank-
ing conserved sequences of the TP21 genome with cor-
responding sequence of E5 strain in the stable infectious
cDNA clone of wild-type LGT strain TP21 (Campbell and
Pletnev, 2000). It should be noted that the seven amino
acids of the consensus sequence that differentiate E5
from its more neurovirulent TP21 parent were retained in
the rescued E5-651 clone. However, sequence analysis
of the genome of the Vero cell culture-rescued E5-651
clone identified eight unique nucleotide differences from
the consensus sequence of E5 virus that developed
during the construction of infectious cDNA (Table 1).
These changes were also present in the plasmid DNA
from which the recovered clone was derived, providing
evidence that the E5-651 clone was derived from cDNA.
Only three of eight nucleotide differences resulted in an
amino acid substitution in structural protein E or non-
structural protein NS4B. Virus rescued in certified Vero
cells appeared to be somewhat more stable than virus
rescued in primary chicken embryonic fibroblast cells.
Following 12 passages of the cDNA-derived E5-651
clone in Vero cells, two new amino acid substitutions
were identified, one in NS2B and the other in NS3.
Additional variation in genome sequence of the CEF cell
culture-recovered E5-651 clone also occurred after 12
passages in the CEF cell line (Table 1).
Similar to its E5 parent, the E5-651 clone was not
neuroinvasive in normal adult mice when a large dose
(106 PFU) was used for intraperitoneal inoculation. How-
ever, difference in neuroinvasiveness of E5-651 clone
compared to its E5 parent became evident when the
more permissive SCID mice were used for evaluation of
this manifestation of virus virulence. The cloned E5-651
virus was 3.4 3 102-fold less virulent than its moderately
attenuated E5 parent and 5.1 3 103-fold less neuroinva-
sive than its progenitor, strain TP21, the parent of E5
(Table 2). This further attenuation exhibited by the res-
cued E5-651 clone compared to its E5 parent was asso-
ciated with a reduced cytopathic effect and plaque size
in simian cell culture. One or more of the three unique
amino acid substitutions in E and NS4B of the cloned
E5-651 (Table 1) virus were responsible for reduced neu-
roinvasiveness of virus in SCID mice and for the re-
stricted plaque phenotype in simian cells.
The 39-noncoding region of tick-borne flaviviruses is
approximately 400–800 nts in length and is predicted to
form stem-and-loop secondary structures (Mandl et al.,
1991; Dobrikova and Pletnev, 1995; Wallner et al., 1995;Mandl et al., 1998) that are thought to play a crucial role
in flavivirus replication (Men et al., 1996; Blackwell and
Brinton, 1997; Chen et al., 1997; Zeng et al., 1998). Re-
ently, Mandl et al. (1998) provided evidence that certain
eletions introduced into the 39 NCR of TBEV genome
educed replicative capacity in cell culture and virulence
or mice. The last 340 nts of the 39-terminal sequence of
BEV strains (designed as “core element”) are more
onserved than the sequence located in the 59 end of the
9-NCR of the genome (“variable region”) that starts just
fter the stop codon of the long open reading frame and
nds just before the core element. The core element
equence of the European subtype (strain Neudoerfl) or
ar Eastern subtype (strain Sofjin) of TBEV is 81 to 82%
omologous to the terminal 340 nts of LGT. In addition,
here is a 94.6–95.8% homology in sequence of the last
5 nts of LGT and the corresponding region of various
BEV strains. This region can potentially form a stem-
nd-loop RNA structure that is thought to be essential for
iral replication. For this reason, we attempted to achieve
reater attenuation of LGT E5 by engineering a 320, 374,
49, or 471 nt deletion that included the variable region
nd extended into the core element of the 39NCR of
lone E5-651 (Fig. 1). Only the cDNA construct with a 320
t deletion between nts 10379 and 10700 yielded RNA
ranscripts that were infectious when transfected into
ertified Vero cells. The larger deletions were lethal. This
ndicated that the minimum 39-NCR terminal sequence
equired for viability of LGT virus was more than 190
ucleotides (as in the nonviable construct pE5-39-374;
ig. 1) but not more than 244 nucleotides (as in the viable
onstruct pE5-39-320). In contrast, the minimum require-
ent for DEN4 virus viability was the last 113 nts at the
9 end (Men et al., 1996), while for TBEV, viability required
minimum sequence 222 nts in length at the 39 end of
enome (Mandl et al., 1998).
The genetic stability of the 39-NCR sequence of the
5-39-320 deletion mutant, its parental E5-651, and E5
irus itself as well as wild-type LGT TP21 strain and its
DNA-generated TP21-656 clone (Campbell and Pletnev,
000) was monitored during long-term serial passage in
ero, LLCMK2, or CEF cells. Sequence of the last 590 nts
f these virus genomes was found to be completely
onserved after cultivation in simian Vero or LLCMK2
cells. It was also true for the 39 end genomic sequence
of E5, E5-651, and E5-39-320 viruses passaged 12 times
in avian CEF cells. In contrast, in CEF cells the genome
of TP21 virus and, more surprisingly, the genome of
cDNA-derived TP21-656 clone was spontaneously mod-
ified by the insertion of a poly(A) track (approximately
100–120 nt in length) into the variable region of the 39
end. The presence of a poly(A) track in the TBEV genome
had already been described as a spontaneous mutation
in certain TBEV strains (Wallner et al., 1995).Analysis of plaque morphology and growth yield
showed that the viable E5-39-320 deletion mutant exhib-
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296 ALEXANDER G. PLETNEVited more restriction in replication on either simian cell
line than that its immediate E5-651 parent (Fig. 2, Table
2). The deletion mutant was noncytopathic in Vero cells
and exhibited a reduced growth capacity of 4 orders of
magnitude compared to the parental E5 or E5-651 clone.
Growth restriction in cell culture has also observed for
the 39-NCR deletion mutants of DEN4 virus (Men et al.,
1996) and TBEV (R-Nd/39D10919; Mandl et al., 1998). This
suggests that most or the entire 39-NCR sequence is
necessary for efficient virus replication.
Finally, neuroinvasiveness of the 39-NCR deletion mutant
was evaluated in the highly permissive SCID mouse model.
Table 2 indicates that the reduction of replication of E5-39-
320 in simian cell culture compared to its immediate E5-651
parent was also associated with an additional 23.5-fold
attenuation in immunodeficient mice. The E5-39-320 mutant
as 1.2 3 105 times more attenuated for SCID mice than its
progenitor, TP21, and approximately 8 3 103 times less
euroinvasive in mice than E5 virus, which had been con-
idered previously as a potential live virus vaccine candi-
ate for protection against disease caused by tick-borne
laviviruses (Price et al., 1970). It should be noted that the
ive E5 virus vaccine candidate exhibited low neuroviru-
ence in monkeys; in fact it induced fewer CNS lesions than
he 17D vaccine strain of yellow fever virus, which is con-
idered to be one of the safest live human vaccine viruses
Nathanson et al., 1968). Evaluation of the E5 strain in
uman volunteers (Price et al., 1970) suggested its potential
alue for the protection against human illness caused by
elated tick-borne flaviviruses.
Ideally, a live attenuated flavivirus vaccine should be
ompletely free of detectable neuroinvasiveness, but this
s often difficult to achieve. For example, the licensed
ellow fever 17D vaccine is able to invade the CNS of
nfant CD-1 mice from a peripheral site of inoculation and
o cause death (Guirafhoo et al., 1999). Vaccine-associ-
ted encephalitis and death of recipients following im-
unization with the 17D yellow fever vaccine acciden-
ally occurred during early clinical trials (Monath and
einz, 1996; Jennings et al., 1994; Merlo et al., 1993). In
the present study the highly attenuated E5-39-320 dele-
tion mutant retained its ability to invade the CNS of
immunodeficient mice and caused severe disease, pos-
sibly as a consequence of a spontaneous single amino
acid substitution (a reversion Gly149 3 Glu) in the E
glycoprotein (Table 3). Interestingly, the mutation at
codon GGG (1415–1417 nts) to AGG in the sequence of
the E5-651 virus leading to amino acid substitution Gly149
to Arg in the E protein was also detected when E5-651
virus was rescued from the full-length infectious cDNA
clone in CEF cells and this became the predominant
sequence following 12 passages in CEF cells (Table 1).
Three of five SCID mice inoculated ip with 10 PFU of CEF
cell culture-derived E5-651 (passage 1) died during the
7-week observed period, whereas deaths were not ob-
served when 10 PFU of Vero cell culture-derived E5-651
c
fvirus (passage 1) was employed for ip inoculation of five
SCID mice. This suggests that the CEF cell culture-
derived virus in which Gly and Arg fluctuate at position
149 in E protein was more virulent than the Vero cell
culture-derived virus, which contains only a Gly residue
at position 149 in E protein. This observation considered
together with the reversion of Gly149 3 Glu observed in
the brain-adapted E5-39-320 virus suggests that amino
acid substitution at position 149 in E protein might have
an important effect on neuroinvasiveness. The amino
acid substitution at position 149 is located in the loop
E0F0 of central domain I in the three-dimensional struc-
ure of the E protein which has been proposed to play
ole in determination of flavivirus virulence (Rey et al.,
995; McMinn, 1997). Also, the Asn154 3 Leu mutation in
the glycosylation site that is located in the loop E0F0 of E
protein domain I significantly decreased neurovirulence
of the TBEV/DEN4 chimeric virus in mice and restricted
virus replication in cell culture (Pletnev et al., 1993). In the
present study, the amino acid changes that occurred in
the same loop of domain I of E protein at position 149 in
LGT E5 derivatives (a change Glu149 3 Gly in the Vero
ell culture-rescued E5-651 virus, a change Gly149 3 Arg
n the CEF cell culture-rescued E5-651 virus or a reverse
utation Gly149 3 Glu in the mouse brain-adapted E5-
9-320 virus; Tables 1 and 3) also affected virus neuro-
nvasiveness for mice. These changes in E glycoprotein
hould be included in the menu of assays to be per-
ormed when vaccine strains are monitored for safety.
Our findings suggest that a high degree of LGT virus
ttenuation is possible to achieve by the gradual accu-
ulation of the amino acid changes in a single virus
ollowing the pathway: TP21 3 E5 3 E5-651 3 E5-39-
20, where the last step in genetic modification, i.e., the
ntroduction of deletion into the 39-NCR of genome, is the
ost crucial event in terms of reduced growth capacity of
irus in cell culture and virus neuroinvasiveness.
The requisite balance between attenuation and immu-
ogenicity of live virus candidate vaccines is often diffi-
ult to achieve. In the present study, the significant ad-
itional attenuation of both recombinant E5 viruses for
mmunodeficient mice was not accompanied by diminu-
ion of immunogenicity or protective efficacy. Complete
rotection of mice against challenge with wild-type LGT
train TP21 was observed when a very low dose of virus
as used for immunization (10 PFU). Previous studies in
ice (Price and Thind, 1973; Pletnev et al., 2000) dem-
nstrated a tight correlation between the level of neutral-
zing antibodies to LGT virus and cross-resistance to
hallenge with other members of the TBEV complex.
ased on our data, it appears that the 39-NCR deletion
utant of E5 has a favorable vaccine profile. However,
ore extensive evaluation of immunogenicity and pro-
ective efficacy of this vaccine candidate against disease
aused by TBEV in mice and monkeys should be per-
ormed in the future.
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297DECREASED NEUROINVASIVENESS IN IMMUNODEFICIENT MICEMATERIALS AND METHODS
Cells and virus preparations
Certified Vero cells (WHO Seed, 143 passage) were
obtained from Novavax Inc. (Rockville, MD). Primary
chicken embryonic fibroblast (CEF) cells were kindly
provided by Dr. Linda Wyatt (NIAID, NIH, Bethesda, MD).
Simian LLCMK2 cells were purchased from the American
Type Culture Collection. Cells were grown in MEM with
1% glutamine, 10% fetal bovine serum, 50 mg/ml genta-
micin, 0.25 mg/ml fungizone at 37°C and 5% CO2. Virus
stocks of the LGT wild-type strain TP21 and its further
attenuated E5 mutants were prepared in Vero cells as
described (Campbell and Pletnev, 2000).
Reverse transcription
Virus present in cell culture supernatant medium was
precipitated with 8% polyethylene glycol 8000 (U.S. Bio-
chemicals, Cleveland, OH) and 0.4 M NaCl overnight at
4°C and concentrated by centrifugation. Total RNA was
extracted from virions using TRI Reagent (Molecular Re-
search Center, Inc., Cincinnati, OH). Reverse transcrip-
tion (RT) was performed with SuperScript II Preamplifi-
cation system (Life Technologies, Gaithersburg, MD) and
an oligonucleotide (oligo) (1445) 59-GCCTGCGGAGGG-
TACCGATATCAGCGGGTGTTTTTCCGAGACACG that is
complementary to the LGT sequence at its 39 terminus,
i.e., nucleotides (nts) 10921–10943, and contains the
EcoRV and KpnI site immediately following the LGT 39
end sequence. Prior to reverse transcription, 5–10 mg of
NA and 100 ng of primer were incubated at 70°C for 5
in and then chilled on ice. RT reaction mixtures con-
ained this heat-denatured RNA plus ingredients of Su-
erscript II kit and 200 U reverse transcriptase in a final
olume of 100 ml. The reaction mixtures were incubated
at 42°C for 2 h and then frozen and used as a template
to generate double-stranded DNA by polymerase chain
reaction (PCR).
PCR
The standard PCR mixture used to produce double-
stranded cDNA contained 0.5 mM of each of the primer
pairs, 200 ng plasmid DNA or 5–10 ml of RT product as a
template, 400 mM of dNTPs, 13 buffer, and 5 U Takara
LA Taq DNA polymerase (Takara LA PCR Kit, PanVera
Co., Madison, WI) in a total reaction volume of 100 ml.
he reaction mixture was preheated to 94°C for 2 min
nd then subjected to 30 cycles, each cycle being 98°C
or 20 s and 68°C for 15 min.
equence analysis of viral genome
The complete sequence of the genome of (i) E5, (ii) E5
ecovered from cDNA, and (iii) E5 or its derivatives iso-
ated from the brain of moribund mice on day 14 or 28
ostinfection was determined by sequence analysis of
3
sour overlapping RT-PCR cDNA fragments which were
erived directly from virus RNA. The oligo 1445 was used
s a primer to obtain the first-strand cDNA by reverse
ranscription as described above. PCR was performed to
mplify the four overlapping genome fragments: A (nt 1 to
192), B (nt 3491 to 7277), C (nt 6131 to 9669), and D (nt
857 to 10943) using appropriate primers and Takara LA
CR kit. Primers for PCR and sequence analysis were
esigned using previously published LGT sequence
GenBank accession nos. AF253419 and AF253420). PCR
roducts were purified in an agarose gel and isolated
sing a Qiagen gel extraction kit. Sequence of RT-PCR
ragments was determined using BigDye Terminator Cy-
le Sequencing Ready Reaction (PE Applied Biosystems/
BI Prism, Foster City, CA) and a Model 310 Genetic
nalyzer.
onstruction of full-length cDNA clones
1. Construction of full-length cDNA of LGT E5 (Fig. 1A).
long RT-PCR cDNA fragment of E5 genome and plas-
id pTP21-636, which contains full-length infectious
DNA of LGT TP21, was used for this purpose (Campbell
nd Pletnev, 2000). Plasmid pTP21-636 was digested
ith SfiI and AgeI, whose sites were unique in this
ector. Almost full-length cDNA (;10.5 kb) of E5 genome
as produced (Fig. 1A) by high-fidelity PCR using a
ositive-sense primer 1484 that contained the first 23 nts
f LGT sequence, and a negative-sense primer 1107 that
as complementary to the LGT nts 10439–10460 of the 39
erminus. This RT-PCR fragment was derived from a E5
irus suspension of low titer (1.2 3 104 PFU/ml). The PCR
roduct (LGT E5 nts 1–10460) was digested with SfiI and
geI and then cloned into the SfiI(133)–AgeI(9737) part of
he pTP21-636 vector (nucleotide numbers indicate the
irst base of the recognition site sequence and corre-
pond to the full-length sequence of LGT genome), which
ontained a NotI cleavage site, SP6 promoter, and the
irst 133 nts and nts 9737–10943 of LGT TP21 genome
hat are completely conserved in E5. There were also
coRV and KpnI cleavage sites, which were incorporated
nto the LGT cDNA immediately downstream of the 39end
f genome (Fig. 1). The resulting pE5 clones that con-
ained LGT E5 were identified by restriction enzyme
nalysis and sequence analysis of genomic regions
here TP21 and E5 genomes differed. Six individual
ull-length E5 cDNA clones (plasmids pE5) were stable in
he plasmid vector when propagated in Escherichia coli.
he complete viral sequence one of these six plasmids
as determined; this plasmid was designated as pE5-
51 and the corresponding number was used to desig-
ate rescued virus.
2. Introduction of deletions into full-length LGT E5
DNA (Figs. 1B and 1C). To introduce deletions into the
9 noncoding region of the E5 genome, PCR-generated
ubfragments between the AgeI site (nt 9737) and the
am
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298 ALEXANDER G. PLETNEVKpnI site at the 39 end were cloned in the p624-3 vector
(Campbell and Pletnev, 2000), which contains these
unique cleavage sites. The unique AflII site (nt 10379)
was introduced downstream of the TAA-stop codon in
the 39 NCR of E5-651 genome (Figs. 1B and 1C). The first
PCR-amplified fragment was produced using pE5-651
plasmid as a template and the positive-sense primer
(oligo 1013) that contains 9603–9623 nts of LGT genome
and the negative-sense primer (oligo 1638) 59-TTG-
GACTCCTTGCTTAAGGCTTTAAAATATTGAGCTCTC (the
AflII site sequence is in bold and the stop anticodon is
underlined). This PCR fragment was digested with AgeI
nd AflII. Four deletions downstream of AflII site, 320,
374, 449, or 471 nts in length were introduced by PCR
using the negative-sense primer (oligo 1445), which con-
tains the complementary sequence of the last 23 nts at
the LGT 39 terminus and the EcoRV and KpnI site and the
positive-sense primer (oligo 1640, 1641, 1642, or 1643),
which contains the targeted deletion sequence and the
flanking AflII site. The sequence of these mutagenic
primers were as follows: for the 320 nt deletion between
10379 and 10700 nts, oligo 1640, 59-ACTGGGCGTTATCT-
TAAGGCCCCAGGGGGGAAACCCCTG; for the 374 nt de-
letion between 10379 and 10754 nts, oligo 1641, 59-
GGATATTTCCTCCTTAAGATACCAAATGTCCCCTCGTCA;
for the 449 nt deletion between 10379 and 10829 nts,
oligo 1642, 59-CCCCTCGTCAGACTTAAGGGGGGGCG-
GTTCTTGTTCTCC; for the 471 nt deletion between 10379
and 10851 nts, oligo 1643, 59-ACGGACGTGCGCCTTAA-
GAAACTTTGTGAGACCCCTTGC. PCR fragments were
digested with AflII and KpnI, and then cloned into the
AgeI–KpnI-digested region of the p624-3 vector (Camp-
bell and Pletnev, 2000) together with an AgeI–AflII-frag-
ment derived from first PCR as described above. After
transformation of bacteria with ligation mixtures, the
clones (p624-39-320, p624-39-374, p624-39-449, and p624-
39-471) that contained the targeted deletions in the 39-
NCR of genome were identified by sequence analysis.
Construction of full-length E5 cDNA clones with dele-
tions in 39-NCR of genome was completed by ligation of
plasmid p624-39-320, p624-39-374, p624-39-449, or p624-
39-471, which had been digested with NotI and AgeI, and
the NotI–AgeI fragment of pE5-651. The stable individual
full-length E5 cDNA clones (pE5-39-320, pE5-39-374, pE5-
39-449, and pE5-39-471), which contained deletion of 320,
374, 449, or 471 nts in length at 39-NCR of genome, were
identified by sequence analysis.
RNA transcription, transfection, and recovery of virus
Each of the stable pE5 plasmids containing full-length
LGT cDNA (Fig. 1) was linearized with EcoRV, extracted
with phenol-chloroform, and ethanol precipitated. For in
vitro RNA synthesis, the transcription reaction mixture
contained 5 mg of linearized DNA; 1 mM cap analog
7G(59)ppp(59)G (New England BioLabs, Beverly, MA);
o.5 mM each ATP, CTP, and UTP; 10 mM DTT; 13 poly-
erase buffer; 100 U of RNase inhibitor; 50 U of SP6 RNA
olymerase (Promega, Madison, WI) in a volume of 100
ml. The reaction mixture was incubated at 37°C for 1 h,
and the DNA template was then digested with 3 U of RQ1
DNase (Promega) for 10 min at 37°C. The typical yield of
RNA was approximately 10 mg as determined by agarose
gel electrophoresis analysis.
RNA transcripts of the full-length LGT constructs were
used to transfect subconfluent monolayers of CEF cells
or simian Vero cells in the presence of transfection
reagent LipofectAmine (GIBCO BRL, Gaithersburg, MD).
On day 5 and again on days 10, 15, and 20, cells were
split and passaged. Cells cultured in slide chambers
were examined on each of these occasions by immuno-
fluorescence assay (IFA) for the presence of LGT pro-
teins using a LGT-specific mouse antiserum or LGT-
specific hyperimmune mouse ascitic fluid. When 80–
100% of cells were positive by IFA, the contents of
infected T-75 flasks were collected, frozen, and later
used for characterization of cDNA-derived LGT virus.
These recombinant LGT viruses were amplified only
once in simian Vero or CEF cells, after which viral RNA
was isolated and reverse transcribed for cDNA amplifi-
cation and sequence analysis. In a similar manner, the
sequence of the Vero cell-derived or CEF cell-derived
clone E5-651 was determined after an additional 11 pas-
sages in the corresponding cell line or after plaque-to-
plaque purification on LLCMK2 cells and one round of
amplification on Vero cells.
The procedures used for plaque assay and analysis of
replication in cell culture were described earlier (Pletnev
et al., 1992, 1993). Also, the immunostaining focus-form-
ing assay (Ishimine et al., 1987) was used in parallel with
the plaque assay for determination of virus titer, because
the recombinant viruses did not produce distinct plaques
in Vero cells. Serial 10-fold dilution of virus suspension in
MEM containing 2% heat-inactivated fetal bovine serum
(FBS) were inoculated (0.2 ml) into duplicate wells of
6-well or 24-well tissue culture plates containing mono-
layer of Vero or LLCMK2 cells. After 1 h of absorption at
37°C, inoculum was removed and cells in 6-well plates
were overlaid with agar and stained to reveal plaques
with neutral red 7 days later. Cells in 24-well plates were
overlaid with MEM containing 2% FBS, 50 mg/ml genta-
micin, 0.25 mg/ml fungizone, and 1% tragacanth gum
Sigma Chemical Co., St. Louis, MO) and incubated for 4
ays at 37°C and 5% CO2. Medium was removed, and
he cell monolayers fixed for 30 min with methyl alcohol
nd rinsed twice with PBS. Cells in the wells were
reated sequentially with 1:1000 diluted LGT-specific
ouse antibodies and peroxidase-labeled polymer con-
ugated to anti-mouse immunoglobulins (Dako Co.,
arpinteria, CA) diluted 1:10 in PBS. Antibody-bound foci
f infectious cells were developed using 0.01% H2O2 and
0.04% 3,39-diaminobenzidine (Sigma) in PBS and
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299DECREASED NEUROINVASIVENESS IN IMMUNODEFICIENT MICEcounted, and virus titer was expressed as a focus-form-
ing unit per milliliter (FFU/ml).
Evaluation of cDNA-derived viruses in mice
In a previous study it was observed that immunodefi-
cient (SCID) mice were 107 to 108 times more sensitive
for detection of neuroinvasiveness than outbred Swiss
mice (Pletnev and Men, 1998). For this reason SCID mice
were used for assay of neuroinvasiveness of LGT cDNA-
derived virus E5 and its 39-NCR deletion mutant. In this
assay, female 3-week-old C.B.-17 Icr/scid/scid mice (Tac-
onic Farms, Germantown, NY) in groups of 5 were inoc-
ulated ip with decimal dilutions of cDNA-derived E5
(clone 651) and its 39-NCR deletion mutant. These mice
were observed for mortality for 7 weeks.
Blood, liver, and brain of moribund mice which exhib-
ited signs of advanced encephalitis were harvested and
a 10% tissue suspension was prepared in MEM, frozen,
and later used for virus isolation and sequence analysis.
Titer of virus in these tissue suspensions was deter-
mined by plaque assay or focus-forming assay using
monolayers of Vero or LLCMK2 cells. One hundred mi-
croliters of the 10% tissue suspension was used for
isolation of RNA, reverse transcription, cDNA amplifica-
tion by PCR, and sequence analysis of recovered virus
as described above. Also, the mouse brain isolate of
E5-651 or E5-39-320 virus was amplified in Vero cells and
evaluated in the three-week-old SCID mice in groups of
5 that were inoculated ip with decimal dilutions of virus.
Immunogenicity of parental E5 and recombinant E5-
651 or E5-39-320 viruses was evaluated in three-week-
old female Swiss mice that were inoculated ip with 10,
102, 103, or 104 PFU. On day 22 postinoculation, mice
were bled to evaluate antibody response, challenged ip
the next day with 2000 ip LD50 of TP21 virus, and ob-
served for an additional 4 weeks.
For determination of LGT virus-neutralizing antibody
titers, 10-fold diluted serum was heat inactivated for 30
min at 56°C. Serial twofold dilutions of serum (starting at
a serum dilution of 1:10) were mixed with equal volume
of TP21 virus suspension containing approximately 100
FFU. The mixture was incubated for 30 min at 37°C, and
0.1 ml was added to duplicate wells of LLCMK2 cells in a
4-well plate. After 1 h of absorption at 37°C, inoculum
as removed and cells were overlaid with MEM contain-
ng 2% FBS, 50 mg/ml gentamicin, 0.25 mg/ml fungizone,
nd 1% tragacanth gum and titrated for infectious virus
sing the focus-forming assay as described above. An-
ibody titer was the highest dilution of antibody that
educed focus formation 50% compared to serum col-
ected from nonimmunized mouse.
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